HOME >> BIOLOGY >> NEWS
European Federation of Biotechnology and Elsevier announce launch of biotechnology journal

Amsterdam, 5 February 2007 Elsevier will launch Biotechnology, the Journal, as the official publication of the European Federation of Biotechnology (EFB) in September 2007. Biotechnology, the Journal will be a cross-disciplinary research and review journal aimed at an audience of academic and commercial bioscientists who are interested not only in science but also in its translation and use. The bi-monthly journal will be a platform for peer-reviewed articles and editorial comments related to biotechnology.

Editor-in-Chief of the journal will be John Hodgson who was Editor of Trends in Biotechnology and Senior Editor of Nature Biotechnology. Hodgson is one of the founders of the biotech consultancy firm, Critical I. According to Hodgson, Biotechnology, the Journal will have a global reach in content and subscription base. "It is important for the credibility of Biotechnology, the Journal that it publishes the best in science and reflects technical and political discussion in an entirely international context. The journal will be inclusive, reaching eastward and westward, seeking the excitement and opportunity in the sciences, technologies and businesses behind biotechnology."

The launch of this exciting journal is planned to coincide with the start of ECB13, The European Congress on Biotechnology, which will be held from September 16th 19th in Barcelona, Spain. EFB Secretary General Christian Suojanen comments, "We are extremely pleased to be able to launch the journal with both John Hodgson and Elsevier as partners. Biotechnology, the Journal, will seek to reflect the EFB's recognition that the boundaries of science and commerce do not stop at the borders of the European Union, and that it is vital that Biotechnology, the Journal provides the global context that our members need. We firmly believe that the journal will be a success and thus aid in serving both our members and the life sciences community as a whole."


'"/>

Contact: Kate Alzapiedi
k.alzapiedi@elsevier.com
31-204-853-836
Elsevier
5-Feb-2007


Page: 1

Related biology news :

1. European Science Foundations Forward Look reaches out beyond the endless frontiers
2. The UAB heads a European research project on proteases and pathological processes
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
5. Early Europeans unable to stomach milk
6. European launch of International Polar Year 2007-2008
7. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
8. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
9. European launch of International Polar Year 2007-2008
10. Putting a face on the earliest modern Europeans
11. European Union outpaces United States on chemical safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: